595 - Inappropriate intensity statin therapy causing worse lipid profiles in HIV-infected individuals after acute coronary syndrome

Autor: Boccara, F., Miantezila-Basilua, J., Mary-Krause, M., Lang, S., Teiger, E., Funck-Brentano, C., Girard, P.M., Costagliola, D., Cohen, A., Guiguet, M.

Publikováno v: In Archives of Cardiovascular Diseases Supplements January 2017 9(1):110-110

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.

Autor: Terzić V; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Miantezila Basilua J; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Billard N; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France., de Gastines L; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Belhadi D; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France.; Université Paris Cité, IAME, INSERM, Paris, France., Fougerou-Leurent C; Pharmacology Unit, University Hospital Rennes, CIC Inserm 1414, University Hospital Rennes, Rennes, France., Peiffer-Smadja N; Infectious Diseases Department, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.; Université Paris Cité, IAME, INSERM, Paris, France., Mercier N; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Delmas C; Pôle de Recherche Clinique, INSERM, Paris, France., Ferrane A; Pôle de Recherche Clinique, INSERM, Paris, France., Dechanet A; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France., Poissy J; UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, Inserm U1285, CHU Lille, Pôle de réanimation, CNRS, Lille, France., Espérou H; Pôle de Recherche Clinique, INSERM, Paris, France., Ader F; Département des Maladies infectieuses et tropicales, Hospices Civils de Lyon, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ Lyon, Lyon, France., Hites M; Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB)-Erasme, Brussels, Belgium., Andrejak C; Pulmonolgy Unit, University Hospital Amiens-Picardie, UR 4294 AGIR, Université Picardie Jules Verne, Amiens, France., Greil R; IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center for clinical Cancer and Immunology Trials (SCRI-CCCIT), Cancer Cluster Salzburg, Austrian Group for Medical Tumor Therapy (AGMT), Salzburg, Austria., Paiva JA; Serviço de Medicina Intensiva, Centro Hospitalar Universitário São João, Porto, Portugal., Staub T; Infectious Diseases Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg., Tacconelli E; Infectious Diseases, Dept. Diagnostic and Public Health, University of Verona, Verona, Italy., Burdet C; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France., Costagliola D; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France., Mentré F; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France.; Université Paris Cité, IAME, INSERM, Paris, France., Yazdanpanah Y; Université Paris Cité, IAME, INSERM, Paris, France.; Infectious Diseases Department, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.; ANRS|Emerging Infectious Diseases, Paris, France., Diallo A; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 382-391.